Covalis Capital’s Gentex GNTX Stock Holding History

Covalis Capital’s Portfolio GNTX Stock Details GNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,734,804	Closed	-$40.4M	–	135
2025 Q4	$40.4M	Buy	1,734,804 +1,076,138	+163%	+$25.9M	2.83%	8
2025 Q3	$18.6M	Buy	+658,666	New	+$17.5M	2.17%	15
2024 Q1	–	Sell	-145,091	Closed	-$4.74M	–	63
2023 Q4	$4.74M	Buy	+145,091	New	+$4.48M	0.77%	38

Other funds holding GNTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Covalis Capital's GNTX Position: Q1 2026 in Review

Covalis Capital sold out of Gentex (GNTX) in Q1 2026, closing a stake of 1,734,804 shares — an estimated $40.4M sold.

Covalis Capital first reported a position in GNTX in Q4 2023 and held it in 3 quarters. The position peaked at $40.4M in Q4 2025. 501 funds tracked by Wall St. Rank hold GNTX as of Q1 2026.

Covalis Capital reported no remaining Gentex position as of Q1 2026 after selling out during the quarter.
Covalis Capital sold 1,734,804 Gentex shares in Q1 2026, an estimated $40.4M.
Covalis Capital first reported a position in Gentex in Q4 2023 and held it in 3 quarters.
Covalis Capital's Gentex position peaked at $40.4M in Q4 2025.
501 funds tracked by Wall St. Rank held Gentex as of Q1 2026.

Based on Covalis Capital's 13F filing for Q1 2026, filed 15 May 2026.